<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on November 20, 2026 at 3:31 pm by All in One SEO Pro v5.0.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://sakaradigital.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Sakara Digital</title>
		<link><![CDATA[https://sakaradigital.com]]></link>
		<description><![CDATA[Sakara Digital]]></description>
		<lastBuildDate><![CDATA[Fri, 20 Nov 2026 01:32:27 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://sakaradigital.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-reference-architecture-500-person-biotech/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-reference-architecture-500-person-biotech/]]></link>
			<title>AI Reference Architecture for a 500-Person Biotech (Not a Top 20 Pharma)</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:32:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/patient-centric-drug-development-operational/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/patient-centric-drug-development-operational/]]></link>
			<title>Patient-Centric Drug Development: How to Make It Operational, Not Just Aspirational</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:32:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/gxp-saas-exit-clauses-data-portability/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/gxp-saas-exit-clauses-data-portability/]]></link>
			<title>Exit Clauses for GxP SaaS: Data Portability You Need in the Contract</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:30:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/batch-release-data-quality-scorecard/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/batch-release-data-quality-scorecard/]]></link>
			<title>A Data Quality Scorecard for the Batch Release Package</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:30:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/biotech-it-support-models/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/biotech-it-support-models/]]></link>
			<title>IT Support Models for a 100-Person Biotech: In-House, Outsourced, or Both</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:30:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ctms-selection-first-phase-2-biotech/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ctms-selection-first-phase-2-biotech/]]></link>
			<title>CTMS Selection for a Biotech Running Its First Phase 2 Trial</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:30:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/compliance-officer-strategic-advisor-ai/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/compliance-officer-strategic-advisor-ai/]]></link>
			<title>The Compliance Officer as Strategic Advisor: Evolving the Role With AI</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:29:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/pharma-ai-ethics-review-board-charter-template/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/pharma-ai-ethics-review-board-charter-template/]]></link>
			<title>The Pharma AI Ethics Review Board Charter Template</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:29:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/computer-vision-qa-pharma-packaging-when-math-works/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/computer-vision-qa-pharma-packaging-when-math-works/]]></link>
			<title>Computer Vision QA in Pharma Packaging: When the Math Works</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:29:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/upskilling-life-sciences-workforce-ai/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/upskilling-life-sciences-workforce-ai/]]></link>
			<title>Upskilling the Life Sciences Workforce for AI: A Practical Approach</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:29:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-search-controlled-documents-effective-version/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-search-controlled-documents-effective-version/]]></link>
			<title>AI Search Over Controlled Documents: Making Sure Users Only See the Effective Version</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:29:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/sequence-ai-investment-plan-board-3-years/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/sequence-ai-investment-plan-board-3-years/]]></link>
			<title>How to Sequence an AI Investment Plan With Your Board Across 3 Years</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:29:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-business-case-pharma-leadership/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-business-case-pharma-leadership/]]></link>
			<title>Building the AI Business Case in Pharma: What Leadership Needs to See</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:28:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fractional-leader-role-ai-adoption-experimentation-enterprise/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fractional-leader-role-ai-adoption-experimentation-enterprise/]]></link>
			<title>From Experimentation to Enterprise: The Fractional Leader Role in AI Adoption</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:28:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/common-data-layer-regulatory-manufacturing-convergence/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/common-data-layer-regulatory-manufacturing-convergence/]]></link>
			<title>The Common Data Layer for Regulatory and Manufacturing Convergence</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:28:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/executive-kpi-three-different-numbers-reporting-quick-wins/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/executive-kpi-three-different-numbers-reporting-quick-wins/]]></link>
			<title>Why Your Executive KPI Has Three Different Numbers: Three Reporting Quick Wins</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:28:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/when-data-fabric-fails-pharma-5-warning-signs-real-deployments/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/when-data-fabric-fails-pharma-5-warning-signs-real-deployments/]]></link>
			<title>When Data Fabric Fails in Pharma: 5 Warning Signs from Real Deployments</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:28:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ich-q10-knowledge-management/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ich-q10-knowledge-management/]]></link>
			<title>Knowledge Management Under ICH Q10: Turning Tribal Knowledge Into Searchable Records</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:27:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/risk-based-monitoring-data-flows-ich-e6-r3/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/risk-based-monitoring-data-flows-ich-e6-r3/]]></link>
			<title>Risk-Based Monitoring Data Flows Under ICH E6(R3): Designing for Traceability</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:27:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/biotech-under-200-people-should-not-build-in-house/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/biotech-under-200-people-should-not-build-in-house/]]></link>
			<title>What a Biotech Under 200 People Should Not Build In-House</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:27:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/digital-adoption-solutions-overlay-to-native/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/digital-adoption-solutions-overlay-to-native/]]></link>
			<title>What if every user could perform at full capacity the moment they log in?</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:27:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quality-culture-pulse-survey-quarterly-cadence/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quality-culture-pulse-survey-quarterly-cadence/]]></link>
			<title>Quality Culture Pulse Survey: A Quarterly Cadence for Pharma Teams</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:27:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/deviation-trending-analytics-excel-to-dashboards/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/deviation-trending-analytics-excel-to-dashboards/]]></link>
			<title>Deviation Trending Analytics: From Excel to Real-Time Dashboards</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:27:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/recall-readiness-data-first-four-hours/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/recall-readiness-data-first-four-hours/]]></link>
			<title>Recall Readiness: The Data You Need in the First Four Hours</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:26:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/sakara-signals-september-12-2025-beyond-the-algorithm-strategy-stewardship-and-scale/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/sakara-signals-september-12-2025-beyond-the-algorithm-strategy-stewardship-and-scale/]]></link>
			<title>Sakara Signals | September 12, 2025 – Beyond the Algorithm: Strategy, Stewardship, and Scale</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:25:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/data-quality-pharmacovigilance-case-intake-failure-points/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/data-quality-pharmacovigilance-case-intake-failure-points/]]></link>
			<title>Data Quality for Pharmacovigilance Case Intake: Five Failure Points</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:21:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/pharma-cio-quarterly-board-update-template/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/pharma-cio-quarterly-board-update-template/]]></link>
			<title>The Pharma CIO&#8217;s Quarterly Board Update Template</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:21:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/site-activation-acceleration-playbook-phase-ii/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/site-activation-acceleration-playbook-phase-ii/]]></link>
			<title>The Site Activation Acceleration Playbook for Phase II Studies</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:21:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/master-data-quality-cell-therapy-three-patterns/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/master-data-quality-cell-therapy-three-patterns/]]></link>
			<title>Master Data Quality for Cell Therapy: Three Critical Patterns</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:21:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/data-quality-cleanup-before-ai-mid-cap-pharma/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/data-quality-cleanup-before-ai-mid-cap-pharma/]]></link>
			<title>The Data Quality Cleanup That Came Before AI: A Mid-Cap Pharma Case Pattern</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:21:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/patient-data-privacy-clinical-research/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/patient-data-privacy-clinical-research/]]></link>
			<title>Patient Data Privacy in Clinical Research: Navigating GDPR and FDA Expectations</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:21:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/measuring-roi-ai-investments-life-sciences/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/measuring-roi-ai-investments-life-sciences/]]></link>
			<title>Measuring ROI from AI Investments in Life Sciences</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:20:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/eqms-migration-deviation-capa-data-cleanup/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/eqms-migration-deviation-capa-data-cleanup/]]></link>
			<title>Cleaning Legacy Deviation and CAPA Data Before an eQMS Migration</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:20:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-section-site-master-file/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-section-site-master-file/]]></link>
			<title>Writing the AI Section of a Site Master File</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:20:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/oee-line-performance-analytics-pharma-packaging/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/oee-line-performance-analytics-pharma-packaging/]]></link>
			<title>OEE and Line Performance Analytics in Pharma Packaging</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:20:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/clinical-trial-diversity-action-plans-data-systems/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/clinical-trial-diversity-action-plans-data-systems/]]></link>
			<title>Clinical Trial Diversity Action Plans: The Data and Systems Behind the Commitment</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:20:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/pharma-ai-vendor-evaluation-scorecard-30-questions-buyers-guide/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/pharma-ai-vendor-evaluation-scorecard-30-questions-buyers-guide/]]></link>
			<title>The Pharma AI Vendor Evaluation Scorecard: 30 Questions for Your Buyer&#8217;s Guide</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:20:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fractional-data-officer-small-pharma-strategic-data-leadership/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fractional-data-officer-small-pharma-strategic-data-leadership/]]></link>
			<title>The Fractional Data Officer: When Small Pharma Needs Strategic Data Leadership</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:19:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/reskilling-quality-team-ai-oversight-6-month-curriculum/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/reskilling-quality-team-ai-oversight-6-month-curriculum/]]></link>
			<title>Reskilling Your Quality Team for AI Oversight: A 6-Month Curriculum</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:19:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/first-right-sided-investigation-workshop/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/first-right-sided-investigation-workshop/]]></link>
			<title>The First Right-Sided Investigation Workshop We Run With Clients</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:19:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/dct-tech-stack-cardiovascular-outcomes-studies/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/dct-tech-stack-cardiovascular-outcomes-studies/]]></link>
			<title>Decentralized Trial Tech Stack for Cardiovascular Outcomes Studies</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:19:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/build-partner-buy-ai-decisions-pre-commercial-biotech/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/build-partner-buy-ai-decisions-pre-commercial-biotech/]]></link>
			<title>When to Build vs. Partner vs. Buy: AI Decisions for Pre-Commercial Biotech</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:19:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quality-vs-completeness-prioritize-data-cleanup-ai-readiness/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quality-vs-completeness-prioritize-data-cleanup-ai-readiness/]]></link>
			<title>Quality vs. Completeness: How to Prioritize Data Cleanup for AI Readiness</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:19:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/protocol-optimization-ai-simulation/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/protocol-optimization-ai-simulation/]]></link>
			<title>Protocol Optimization with AI Simulation: A Practical Overview</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:18:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/enterprise-ai-token-consumption-cost/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/enterprise-ai-token-consumption-cost/]]></link>
			<title>Managing Token Consumption and Cost in Enterprise AI Tools</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:18:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/digital-provenance-training-data-gxp-decisions/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/digital-provenance-training-data-gxp-decisions/]]></link>
			<title>Digital Provenance for Training Data Used in GxP Decisions</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:18:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/field-force-data-privacy-consent-hcp-engagement/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/field-force-data-privacy-consent-hcp-engagement/]]></link>
			<title>Field Force Data Privacy and Consent: HCP Engagement Under Tightening Rules</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:18:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/clearing-change-control-backlog-90-day-plan/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/clearing-change-control-backlog-90-day-plan/]]></link>
			<title>Clearing a Change Control Backlog: A 90-Day Operating Plan</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:18:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/rpa-to-agentic-retiring-bot-estate-validation/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/rpa-to-agentic-retiring-bot-estate-validation/]]></link>
			<title>From RPA to Agentic: Retiring a Bot Estate Without Breaking Validation</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:17:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/real-world-evidence-data-lakehouse-without-cdisc-migration/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/real-world-evidence-data-lakehouse-without-cdisc-migration/]]></link>
			<title>Building a Real-World Evidence Data Lakehouse Without Migrating CDISC</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 01:08:39 +0000]]></pubDate>
		</item>
				</channel>
</rss>
